Evidence map›Paper›PMID 39766206›Full record

ArticleBiomolecules2024

Therapeutic Potential of

Mario Dioguardi, Stefania Cantore, Diego Sovereto, Lorenzo Sanesi, Angelo Martella, Lynn Almasri, Gennaro Musella, Lorenzo Lo Muzio, Andrea Ballini

Abstract readScoping Review
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mario DioguardiDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.ORCID 0000-0003-0949-3457
Stefania CantoreDepartment of Precision Medicine, University of Campania Luigi Vanvitelli, Via De Crecchio, 7, 80138 Naples, Italy.ORCID 0000-0001-9521-2521
Diego SoveretoDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.
Lorenzo SanesiDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.
Angelo MartellaDataLab, Department of Engineering for Innovation, University of Salento, 73100 Lecce, Italy.ORCID 0000-0002-1082-7293
Lynn AlmasriKing's College London, University of London, Strand, London WC2R 2LS, UK.
Gennaro MusellaDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.ORCID 0009-0005-3576-4670
Lorenzo Lo MuzioDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.ORCID 0000-0003-4633-4893
Andrea BalliniDepartment of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122 Foggia, Italy.ORCID 0000-0001-8758-1415

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntsAnt VenomsAnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsFire AntsHumansNeoplasmsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAnt Venomsangiogenesisantimicrobialcancercandidadrug discoveryhead and neck squamous cell carcinomas (HNSCCs)RIFASolenopsis invictatumourvenom

Identifiers

PMID39766206
PMCPMC11673062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.